// App-Quantinova.ai

: A broad immunological screening may impact treatment in bronchiectasis patients

Researchers

Presenter

  • Elisa Franceschi

Principal Investigators

  • Barbara Vigone

  • Giovanni Sotgiu

  • Michele Gaffuri

  • Andrea Gramegna

  • Carlotta Di Francesco

  • Alice Gelmini

  • Laura Saderi

  • Martina Dettori

  • Manuela Seia

  • Marco Mantero

  • Pieter Goeminne

  • James Chalmers

  • Stefano Aliberti

  • Francesco Blasi

Medical Centers

  • Department of Pathophysiology and Transplantation, University of Milano, Italy. Respiratory Disease and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore, Policlinico, Milano, Italy., Milano (MI, Italy

  • Department Immunology and Allergology, University of Milan; Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

  • Clinical Epidemiology and Medical Statistics Unit; Department of Medical, Surgical and Experimental, Università degli Studi di Sassari, Sassari, Italy

  • Department of Otolaryngology and Head and Neck Surgery, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico and Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy

  • Genetics Laboratory, IRCCS Ca’ Granda Foundation, Milan, Italy

  • Department of Respiratory Disease, AZ Nikolaas, Sint-Niklaas, Belgium; Department of Respiratory Disease, UZ Leuven, Leuven, Belgium

  • Scottish Centre for Respiratory Research, Ninewells Hospital and Medical School, Dundee, United Kingdom

Locations

  • Italy

  • Belgium

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Cystic Fibrosis

Biomarkers

  • anti-CCP antibodies

  • Cluster of differentiation 79A

  • Immunoglobulin E

  • Immunoglobulin G

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved